Renovos Biologics

Private

SouthamptonHealthcare & Life Scienceshttps://www.renovos.co.uk/

Last Round

Series A

Nov 20, 2023

Total Funding Raised

$1.12M

Company Overview

Renovos Biologics is a biotechnology company that develops synthetic nanoclay gel platforms for regenerative medicine and therapeutic delivery.

Sector

Healthcare & Life Sciences

Verticals

Biotechnology, Medical Devices, Advanced Materials, Drug Discovery

Business Model

B2B

Customer Profile

Services & Consulting, Data as a Service

AI Layer

Non-AI

Keywords

regenerative medicineorthobiologicsdrug delivery platformnanoclay scaffoldbone regenerationtissue repairbone morphogenetic protein-2BMP-2mesenchymal stem cellsbiomaterialsinjectable hydrogelorthopaedic devicesbiotech licensingbio-scaffoldtissue engineering

Historical Pricing

Historical view of private secondary pricing and transaction trends.

Unlock Pricing Charts

Caplight Momentum Score

Proprietary index based on bid/ask volume and sentiment.

View Momentum History

Track how buyer interest and sentiment changes over time.

Renovos Biologics Comps

Public and private peers based on sector, stage, and business model.

Renovos Biologics comps — public and private peers by sector, stage, and business model
Company	Status	Est. Valuation	Rev Multiple
OpenAI	Private	$86.0B	~40x
Cohere	Private	$5.0B	--
Competitor 1	Public	$XX.XB	XXx
Competitor 2	Public	$XX.XB	XXx

View Full Comps Set

Access detailed peer comparisons, multiples, and valuation benchmarks.

Renovos Biologics Funding Rounds

Historical fundraising activity

Data table
Round	Date	Amount Raised	Valuation	Investors	Sources
Series A	Nov 20, 2023
Grant	Feb 23, 2022
Seed	Feb 3, 2020

View all Funding Rounds

Key People

Founding team and executive leadership

Jonathan Dawson

Founder and CTO

Founding Team

Agnieszka Janeczek

Founder CEO

Founding Team

Renovos Biologics Investors

Notable investors and investment history

Renovos Biologics investors
Investor	Rounds
Innovate UK	Grant
HS.	Seed
Henley Business Angels	Series A
Orthopaedic Research UK	Series A, Seed

View all Investors

Renovos Biologics Filings

SEC and related filings with document metadata.

Data table
Typed	Date	Amount Offered	Amount Sold	Filling	Pages	Download
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation
Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation	Sign Up to view	Mock Valuation

Renovos Biologics Filings

SEC and related filings with document metadata.

Frequently Asked Questions

Common questions about Renovos Biologics's valuation, stock price, and market status.

Firmographic Details

HeadquartersSouthampton

Employee Range10

Year Founded2017

Last FundingNov 20, 2023

Institutional Data Access

Join leading institutional investors using Caplight to access private market data, discover pricing, and execute secondary block trades.

Requires verified institutional or accredited status.